Amin Impex Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.15 M
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 92.03%
- Profit Growth 230.30%
- Ebitda 263.45%
- Net Worth 29.45%
- Total Assets 35.86%
About Amin Impex
Amin Impex Private Limited (AIPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 February 2011 and has a history of 13 years and 11 months. Its registered office is in New Delhi, Delhi, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
New Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51900DL2011PTC214471
-
Company No.
214471
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Feb 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Amin Impex Private Limited offer?
Amin Impex Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Fitness Supplements, Bird Food, Poultry & Animal Food, Fish Foods, Pet Furniture & Products, Pet Grooming Tools.
Who are the key members and board of directors at Amin Impex?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Inderjit Singh
|
Director | 21-Feb-2011 | Current |
|
Amit Kumar
|
Director | 21-Feb-2011 | Current |
Financial Performance of Amin Impex.
Amin Impex Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 92.03% increase. The company also saw a substantial improvement in profitability, with a 230.3% increase in profit. The company's net worth Soared by an impressive increase of 29.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amin Impex?
In 2023, Amin Impex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Teleios Pharma Private LimitedAmit Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amin Impex?
Unlock and access historical data on people associated with Amin Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amin Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amin Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
